Mouse study of combined DNA/protein COVID-19 vaccine to boost high levels of antibody and cell mediated immune responses

Qian Hea National Institute for Food and Drug Control, Beijing, People’s Republic of ChinaView further author information

Shuying Liub SYL-Consulting, Thousand Oaks, CA, USAView further author information

Zhenglun Lianga National Institute for Food and Drug Control, Beijing, People’s Republic of ChinaView further author information

Shan Luc Laboratory of Nucleic Acid Vaccines, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USACorrespondence[email protected]
View further author information

Wei Cund Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, People’s Republic of ChinaView further author information

Qunying Maoa National Institute for Food and Drug Control, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Click to increase image sizeClick to decrease image size

Disclosure statement

No potential conflict of interest was reported by the author(s).

Correction Statement

This article has been corrected with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

This work was supported by Emergency Key Program of Guangzhou Laboratory (grant 467 No. EKPG21-30-1).

Mouse study of combined DNA/protein COVID-19 vaccine to boost high levels of antibody and cell mediated immune responses

Information for

Open access

Opportunities

Help and information

Mouse study of combined DNA/protein COVID-19 vaccine to boost high levels of antibody and cell mediated immune responses

Disclosure statement

Correction Statement

Additional information

Funding

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature